Abstract
The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
| Original language | English |
|---|---|
| Pages (from-to) | 582-583 |
| Number of pages | 2 |
| Journal | American Journal of Cardiology |
| Volume | 92 |
| Issue number | 5 |
| DOIs | |
| State | Published - Aug 22 2003 |
Bibliographical note
Funding Information:TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.
Funding
TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.
| Funders | Funder number |
|---|---|
| Merck |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine